ELI LILLY & Co
A research-based company that develops and sells pharmaceutical products.
LLY | US
Overview
Corporate Details
- ISIN(s):
- US5324571083
- LEI:
- Country:
- United States of America
- Address:
- LILLY CORPORATE CTR, 46285 INDIANAPOLIS
- Website:
- https://www.lilly.com/
- Sector:
- Manufacturing
Description
Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-07-24 13:40 |
Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NK…
|
English | 9.0 KB | ||
| 2017-07-07 14:33 |
UK Supreme Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patents
|
English | 4.1 KB | ||
| 2017-06-01 12:45 |
Derica Rice to Retire as Lilly Chief Financial Officer
|
English | 4.1 KB | ||
| 2017-05-01 21:48 |
Eli Lilly Declares Second-Quarter 2017 Dividend
|
English | 1.8 KB | ||
| 2017-04-26 22:30 |
Eli Lilly and Company Files Form [3/4/5]
|
English | 2.0 KB | ||
| 2017-04-25 14:27 |
Lilly Reports First-Quarter 2017 Results
|
English | 43.0 KB | ||
| 2017-03-21 16:17 |
Eli Lilly and Company Calls Stockholders Meeting
|
English | 2.0 KB | ||
| 2017-03-15 20:39 |
Eli Lilly and Company Files Form 10-K
|
English | 1.5 KB | ||
| 2017-03-01 15:52 |
Lilly Completes Acquisition of CoLucid Pharmaceuticals
|
English | 6.8 KB | ||
| 2017-02-09 12:45 |
Carolyn R. Bertozzi, Ph.D., Elected to Lilly Board of Directors
|
English | 3.4 KB | ||
| 2017-02-02 15:04 |
Japan IP High Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patents
|
English | 3.6 KB | ||
| 2017-01-18 13:03 |
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLuc…
|
English | 9.9 KB | ||
| 2017-01-12 17:45 |
U.S. Court of Appeals Rules in Lilly's Favor on Alimta Vitamin Regimen Patent
|
English | 3.9 KB | ||
| 2017-01-05 12:45 |
Lilly to Adjust Organization and Leadership Structure to Better Align with Grow…
|
English | 7.4 KB | ||
| 2016-12-15 14:05 |
Lilly Provides 2017 Financial Guidance and 2016 Update, Reaffirms Financial Exp…
|
English | 16.5 KB |
Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ELI LILLY & Co
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
